MURAE Organisor, a pharmaceutical company in India, will meet on February 13, 2024, to discuss a stock split and bonus issue after reporting a massive rise in revenue and profit for Q3 FY25.
MURAE Organisor, a pharmaceutical company based in India, specializes in the marketing, trading, and distribution of a wide range of pharmaceutical formulation products. The company, which has seen significant growth recently, announced that its Board of Directors will meet on February 13, 2024, to discuss the possibility of a stock split and bonus issue.
This will mark the company’s second bonus issue, following a previous 1:1 ratio bonus issue in 2021. The stock split, which would be the second for MURAE Organisor, is also under consideration. The company had previously reduced the face value of its shares from ₹10 to ₹2 in 2021. MURAE Organisor’s shares have been trading on an ex-split basis since then and are currently priced at ₹1.77 per share, reflecting a 43% increase over the last four months.
In its most recent quarterly performance, MURAE Organisor reported impressive growth. For Q3 FY25, the company saw a 384.3% quarter-on-quarter increase in revenue, bringing the total revenue from operations to ₹281.04 crore, compared to ₹58 crore in the previous quarter. This surge in revenue demonstrates strong market demand and the successful execution of new orders. Along with the revenue growth, MURAE Organisor’s net profit rose by 344.3% to ₹4.01 crore, up from ₹0.90 crore in Q2 FY24.
The company’s profit before tax (PBT) also showed a substantial rise, increasing by 368.5% to ₹5.26 crore from ₹1.12 crore in the previous quarter. Earnings per share (EPS) saw a remarkable fivefold increase, climbing from ₹0.01 to ₹0.06.
MURAE Organisor’s strong performance is attributed to the continued expansion of its global specialty business and its solid manufacturing and institutional sales strategy. The company is focused on growth across its business segments and is projecting high single-digit to low double-digit consolidated topline growth for FY24. The company also plans to leverage its extensive distribution network to drive sales in both domestic and international markets.
With the upcoming Board meeting to consider a stock split and bonus issue, investors are keenly watching for further developments.
